文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Considerations to address missing data when deriving clinical trial endpoints from digital health technologies.

作者信息

Di Junrui, Demanuele Charmaine, Kettermann Anna, Karahanoglu F Isik, Cappelleri Joseph C, Potter Andrew, Bury Denise, Cedarbaum Jesse M, Byrom Bill

机构信息

Pfizer Inc., United States of America.

Pfizer Inc., United States of America.

出版信息

Contemp Clin Trials. 2022 Feb;113:106661. doi: 10.1016/j.cct.2021.106661. Epub 2021 Dec 22.


DOI:10.1016/j.cct.2021.106661
PMID:34954098
Abstract

Digital health technologies (DHTs) enable us to measure human physiology and behavior remotely, objectively and continuously. With the accelerated adoption of DHTs in clinical trials, there is an unmet need to identify statistical approaches to address missing data to ensure that the derived endpoints are valid, accurate, and reliable. It is not obvious how commonly used statistical methods to handle missing data in clinical trials can be directly applied to the complex data collected by DHTs. Meanwhile, current approaches used to address missing data from DHTs are of limited sophistication and focus on the exclusion of data where the quantity of missing data exceeds a given threshold. High-frequency time series data collected by DHTs are often summarized to derive epoch-level data, which are then processed to compute daily summary measures. In this article, we discuss characteristics of missing data collected by DHT, review emerging statistical approaches for addressing missingness in epoch-level data including within-patient imputations across common time periods, functional data analysis, and deep learning methods, as well as imputation approaches and robust modeling appropriate for handling missing data in daily summary measures. We discuss strategies for minimizing missing data by optimizing DHT deployment and by including the patients' perspectives in the study design. We believe that these approaches provide more insight into preventing missing data when deriving digital endpoints. We hope this article can serve as a starting point for further discussion among clinical trial stakeholders.

摘要

相似文献

[1]
Considerations to address missing data when deriving clinical trial endpoints from digital health technologies.

Contemp Clin Trials. 2022-2

[2]
Digital Health Technologies in Clinical Trials: An Ontology-Driven Analysis to Inform Digital Sustainability Policies.

Ther Innov Regul Sci. 2023-11

[3]
How Much Evidence Is Enough? Research Sponsor Experiences Seeking Regulatory Acceptance of Digital Health Technology-Derived Endpoints.

Digit Biomark. 2023-6-8

[4]
Behavioral Engagement and Activation Model Study (BEAMS): A latent class analysis of adopters and non-adopters of digital health technologies among people with Type 2 diabetes.

Transl Behav Med. 2024-7-27

[5]
Monitoring Activity and Gait in Children (MAGIC) using digital health technologies.

Pediatr Res. 2024-8

[6]
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms.

Clin Pharmacol Ther. 2024-5

[7]
Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson's Disease.

Sensors (Basel). 2022-3-9

[8]
Multiple imputation approaches for epoch-level accelerometer data in trials.

Stat Methods Med Res. 2023-10

[9]
Integrating environmental considerations in digital health technology assessment and procurement: Stakeholders' perspectives.

Digit Health. 2023-12-6

[10]
Digital technologies: Innovations that transform the face of drug development.

Clin Transl Sci. 2023-8

引用本文的文献

[1]
Designing digital health interventions with causal inference and multi-armed bandits: a review.

Front Digit Health. 2025-6-5

[2]
AI-Driven Applications in Clinical Pharmacology and Translational Science: Insights From the ASCPT 2024 AI Preconference.

Clin Transl Sci. 2025-4

[3]
Effects of Missing Data on Heart Rate Variability Measured From A Smartwatch: Exploratory Observational Study.

JMIR Form Res. 2025-2-24

[4]
Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective.

Clin Transl Sci. 2025-2

[5]
Participant-Centered Engagement for Sustained Adherence to Smartwatches: A 12-Month Prospective Decentralized Digital Health Study.

Clin Transl Sci. 2025-2

[6]
Implementing sensor-based digital health technologies in clinical trials: Key considerations from the eCOA Consortium.

Clin Transl Sci. 2024-11

[7]
Multiple imputation integrated to machine learning: predicting post-stroke recovery of ambulation after intensive inpatient rehabilitation.

Sci Rep. 2024-10-24

[8]
Smartphone Screen Time Characteristics in People With Suicidal Thoughts: Retrospective Observational Data Analysis Study.

JMIR Mhealth Uhealth. 2024-10-11

[9]
Unleashing the full potential of digital outcome measures in clinical trials: eight questions that need attention.

BMC Med. 2024-9-27

[10]
Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge Exchange event.

Trials. 2024-8-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索